Hsbc Holdings PLC Edwards Lifesciences Corp Put Options Transaction History

Hsbc Holdings PLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 12, 2024	BUY	$84.3 - $94.31 $1.33 Million - $1.49 Million	15,800 New	15,800 $1.46 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $259,644 - $299,211	3,300 Added 18.44%	21,200 $1.77 Million
Q4 2020 Feb 25, 2021	SELL	$71.69 - $91.23 $8.67 Million - $11 Million	-120,958 Reduced 87.11%	17,900 $1.63 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $9.38 Million - $11.9 Million	130,858 Added 1635.73%	138,858 $12.7 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $1.87 Million - $2.44 Million	-27,900 Reduced 77.72%	8,000 $645,000
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $3.76 Million - $4.3 Million	-52,400 Reduced 59.34%	35,900 $8.35 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $4.63 Million - $5.67 Million	75,200 Added 574.05%	88,300 $19.4 Million
Q2 2019 Aug 13, 2019	BUY	$55.74 - $64.41 $529,530 - $611,895	9,500 Added 263.89%	13,100 $2.42 Million
Q2 2018 Aug 10, 2018	SELL	$42.45 - $51.3 $857,490 - $1.04 Million	-20,200 Reduced 84.87%	3,600 $524,000
Q1 2018 May 11, 2018	BUY	$37.19 - $47.45 $885,122 - $1.13 Million	23,800 New	23,800 $3.32 Million

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.